New oral drug for pancreatic cancer nearly doubles survival rate in trials
Jay Shankar June 9, 2026: A new oral drug called daraxonrasib, developed by Revolution Medicines and tested in a global Phase 3 trial,
Drugs
Health
2026 Bundibugyo Ebola outbreak roadmap
HQ Team 21 May, 2026: A presentation of the Ebola outbreak, caused by the rare Bundibugyo virus (BDBV). First identified in the Bundibugyo
Drugs
Health
Pharma
Ebola outbreak deaths at 130, WHO says situation ‘deeply concerning’
The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated
Drugs
Health
Pharma
WHO declares Ebola outbreak in Congo, Uganda, as a public health emergency
The WHO has declared an Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda as a public health emergency following the
Opinion
Science writing in the dumps; sifitng fact from fiction
By Afrinisa May 11, 2026: We are a bunch of science writers. Yes, yes you know we are the kind who go,” Yay!!
Drugs
Health
Opinion
War in the mind: Post traumatic stress disorder and human resilience
The Vietnam War marked a turning point in wartime psychiatry. Many veterans returned to a divided and often unsupportive society. They reported persistent
Climate
Health
Pharma
Global cholera cases decline 17% in March: Global health agency
Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a
Health
Medical
Pharma
Abbott gets FDA nod for software to help doctors open blocked arteries
May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have
Health
Research
Work pressure is killing 840,000 people a year, finds UN report
The hard hat for physical labour saved millions of lives. So did the safety guard on the factory press, the chemical hazard label,
Health
Opinion
Are GLP-1 drugs fuelling an eating disorder crisis globally?
Swati Sri April 27, 2026: Glucon-like Peptides-1 (GLP-1) agonists stabilize blood glucose by stimulating insulin secretion and suppressing glucagon production in the body.